{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:45:36Z","timestamp":1765295136662,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40618-020-01318-1","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T17:30:42Z","timestamp":1591205442000},"page":"1053-1060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?"],"prefix":"10.1007","volume":"43","author":[{"given":"T.","family":"Filardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-9543","authenticated-orcid":false,"given":"S.","family":"Morano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"1318_CR1","unstructured":"World Health Organization (2018) Global report on diabetes. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes. Accessed 17 Mar 2020"},{"key":"1318_CR2","doi-asserted-by":"publisher","first-page":"m606","DOI":"10.1136\/bmj.m606","volume":"368","author":"XW Xu","year":"2020","unstructured":"Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 368:m606. https:\/\/doi.org\/10.1136\/bmj.m606","journal-title":"BMJ"},{"key":"1318_CR3","doi-asserted-by":"crossref","unstructured":"Giorgi Rossi P, Marino M, Formisano D, Venturelli F, Vicentini M, Grilli R, The Reggio Emilia COVID-19 Working Group (2020) Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.04.13.20063545v1. Accessed May 25 2020","DOI":"10.1101\/2020.04.13.20063545"},{"key":"1318_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-020-0754-0","author":"X Zou","year":"2020","unstructured":"Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. https:\/\/doi.org\/10.1007\/s11684-020-0754-0","journal-title":"Front Med"},{"key":"1318_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4683","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.4683","journal-title":"JAMA"},{"key":"1318_CR6","unstructured":"International Diabetes Federation (2019) IDF Diabetes Atlas. https:\/\/www.diabetesatlas.org\/en\/. Accessed 17 Mar 2020"},{"key":"1318_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IJGM.S226010","volume":"13","author":"Y Pinchevsky","year":"2020","unstructured":"Pinchevsky Y, Butkow N, Raal FJ, Chirwa T, Rothberg A (2020) Demographic and clinical factors associated with development of type 2 diabetes: a review of the literature. Int J Gen Med 13:121\u2013129. https:\/\/doi.org\/10.2147\/IJGM.S226010","journal-title":"Int J Gen Med"},{"issue":"2","key":"1318_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","volume":"4","author":"J Pearson-Stuttard","year":"2016","unstructured":"Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J (2016) Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol 4(2):148\u2013158. https:\/\/doi.org\/10.1016\/S2213-8587(15)00379-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1318_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40618-020-01236-2","volume":"43","author":"GP Fadini","year":"2020","unstructured":"Fadini GP, Morieri ML, Longato E, Avogaro A (2020) Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 43(6):867\u2013869. https:\/\/doi.org\/10.1007\/s40618-020-01236-2","journal-title":"J Endocrinol Invest"},{"key":"1318_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001343","author":"Y Yan","year":"2020","unstructured":"Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, Yu X, Dong K (2020) Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001343","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"1318_CR11","first-page":"187","volume":"18","author":"MP Moutschen","year":"1992","unstructured":"Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187\u2013201","journal-title":"Diabete Metab"},{"issue":"3\u20134","key":"1318_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"SE Geerlings","year":"1999","unstructured":"Geerlings SE, Hoepelman AI (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26(3\u20134):259\u2013265. https:\/\/doi.org\/10.1111\/j.1574-695X.1999.tb01397.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1318_CR13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1710018","author":"L Spiezia","year":"2020","unstructured":"Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, Navalesi P, Simioni P (2020) COVID-19-Related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. https:\/\/doi.org\/10.1055\/s-0040-1710018","journal-title":"Thromb Haemost"},{"key":"1318_CR14","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0660","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, Liu C, Xiong M, Deng A, Zhang Y, Zheng L, Huang K (2020) Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. https:\/\/doi.org\/10.2337\/dc20-0660","journal-title":"Diabetes Care"},{"key":"1318_CR15","doi-asserted-by":"publisher","first-page":"154216","DOI":"10.1016\/j.metabol.2020.154216","volume":"107","author":"J Zhou","year":"2020","unstructured":"Zhou J, Tan J (2020) Diabetes patients with COVID-19 need better blood glucose management in Wuhan China. Metabolism 107:154216. https:\/\/doi.org\/10.1016\/j.metabol.2020.154216","journal-title":"Metabolism"},{"issue":"12","key":"1318_CR16","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1097\/HJH.0000000000000350","volume":"32","author":"A Solini","year":"2014","unstructured":"Solini A, Zoppini G, Orsi E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Arosio M, Baroni MG, Penno G, Pugliese G, Renal I, Cardiovascular Events Study G (2014) Resistant hypertension in patients with type 2 diabetes: clinical correlates and association with complications. J Hypertens 32(12):2401\u20132410. https:\/\/doi.org\/10.1097\/HJH.0000000000000350","journal-title":"J Hypertens"},{"issue":"12","key":"1318_CR17","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1681\/ASN.2018040443","volume":"29","author":"V Saglimbene","year":"2018","unstructured":"Saglimbene V, Palmer SC, Ruospo M, Natale P, Maione A, Nicolucci A, Vecchio M, Tognoni G, Craig JC, Pellegrini F, Lucisano G, Hegbrant J, Ariano R, Lamacchia O, Sasso A, Morano S, Filardi T, De Cosmo S, Pugliese G, Procaccini DA, Gesualdo L, Palasciano G, Johnson DW, Tonelli M, Strippoli GFM, Long-Term Impact of RASIoCOI (2018) The long-term impact of renin-angiotensin system (RAS) inhibition on cardiorenal outcomes (LIRICO): a randomized controlled trial. J Am Soc Nephrol 29(12):2890\u20132899. https:\/\/doi.org\/10.1681\/ASN.2018040443","journal-title":"J Am Soc Nephrol"},{"key":"1318_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"issue":"4","key":"1318_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nrendo.2015.6","volume":"11","author":"CA Romero","year":"2015","unstructured":"Romero CA, Orias M, Weir MR (2015) Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol 11(4):242\u2013252. https:\/\/doi.org\/10.1038\/nrendo.2015.6","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1318_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cvr\/cvt245","volume":"101","author":"M Sahara","year":"2014","unstructured":"Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, Nagai R, Sata M (2014) Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Cardiovasc Res 101(2):236\u2013246. https:\/\/doi.org\/10.1093\/cvr\/cvt245","journal-title":"Cardiovasc Res"},{"key":"1318_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","author":"AHJ Danser","year":"2020","unstructured":"Danser AHJ, Epstein M, Batlle D (2020) Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15082","journal-title":"Hypertension"},{"issue":"4","key":"1318_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1124\/pr.118.017129","volume":"71","author":"LB Arendse","year":"2019","unstructured":"Arendse LB, Danser AHJ, Poglitsch M, Touyz RM, Burnett JC Jr, Llorens-Cortes C, Ehlers MR, Sturrock ED (2019) Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacol Rev 71(4):539\u2013570. https:\/\/doi.org\/10.1124\/pr.118.017129","journal-title":"Pharmacol Rev"},{"issue":"5","key":"1318_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1113\/expphysiol.2007.040048","volume":"93","author":"Y Imai","year":"2008","unstructured":"Imai Y, Kuba K, Penninger JM (2008) The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol 93(5):543\u2013548. https:\/\/doi.org\/10.1113\/expphysiol.2007.040048","journal-title":"Exp Physiol"},{"issue":"7047","key":"1318_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436(7047):112\u2013116. https:\/\/doi.org\/10.1038\/nature03712","journal-title":"Nature"},{"key":"1318_CR25","doi-asserted-by":"publisher","first-page":"19840","DOI":"10.1038\/srep19840","volume":"6","author":"H Gu","year":"2016","unstructured":"Gu H, Xie Z, Li T, Zhang S, Lai C, Zhu P, Wang K, Han L, Duan Y, Zhao Z, Yang X, Xing L, Zhang P, Wang Z, Li R, Yu JJ, Wang X, Yang P (2016) Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Sci Rep 6:19840. https:\/\/doi.org\/10.1038\/srep19840","journal-title":"Sci Rep"},{"issue":"1","key":"1318_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","volume":"21","author":"A Khan","year":"2017","unstructured":"Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, Hall R, Poirier G, Ronco JJ, Tidswell M, Hardes K, Powley WM, Wright TJ, Siederer SK, Fairman DA, Lipson DA, Bayliffe AI, Lazaar AL (2017) A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care 21(1):234. https:\/\/doi.org\/10.1186\/s13054-017-1823-x","journal-title":"Crit Care"},{"issue":"4","key":"1318_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/path.2987","volume":"225","author":"RM Wosten-van Asperen","year":"2011","unstructured":"Wosten-van Asperen RM, Lutter R, Specht PA, Moll GN, van Woensel JB, van der Loos CM, van Goor H, Kamilic J, Florquin S, Bos AP (2011) Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1\u20137) or an angiotensin II receptor antagonist. J Pathol 225(4):618\u2013627. https:\/\/doi.org\/10.1002\/path.2987","journal-title":"J Pathol"},{"issue":"1","key":"1318_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.abb.2008.09.019","volume":"481","author":"L Liu","year":"2009","unstructured":"Liu L, Qiu HB, Yang Y, Wang L, Ding HM, Li HP (2009) Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat. Arch Biochem Biophys 481(1):131\u2013136. https:\/\/doi.org\/10.1016\/j.abb.2008.09.019","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"1318_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/SHK.0000000000000302","volume":"43","author":"Y Li","year":"2015","unstructured":"Li Y, Zeng Z, Li Y, Huang W, Zhou M, Zhang X, Jiang W (2015) Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. Shock 43(4):395\u2013404. https:\/\/doi.org\/10.1097\/SHK.0000000000000302","journal-title":"Shock"},{"issue":"12","key":"1318_CR30","first-page":"15670","volume":"8","author":"W Deng","year":"2015","unstructured":"Deng W, Deng Y, Deng J, Wang DX, Zhang T (2015) Losartan attenuated lipopolysaccharide-induced lung injury by suppression of lectin-like oxidized low-density lipoprotein receptor-1. Int J Clin Exp Pathol 8(12):15670\u201315676","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"1318_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10787-018-0535-4","volume":"27","author":"J Boskabadi","year":"2019","unstructured":"Boskabadi J, Askari VR, Hosseini M, Boskabady MH (2019) Immunomodulatory properties of captopril, an ACE inhibitor, on LPS-induced lung inflammation and fibrosis as well as oxidative stress. Inflammopharmacology 27(3):639\u2013647. https:\/\/doi.org\/10.1007\/s10787-018-0535-4","journal-title":"Inflammopharmacology"},{"key":"1318_CR32","unstructured":"Minle S, Yang CY, Timens W, Boss\u00e8 Y, Sin DD (2020) SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors. Lancet Resp. Med. https:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(20)30224-1\/fulltext - %2520. Accessed May 25 2020"},{"issue":"3","key":"1318_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63(3):364\u2013374. https:\/\/doi.org\/10.1007\/s11427-020-1643-8","journal-title":"Sci China Life Sci"},{"key":"1318_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1855","author":"N Mehta","year":"2020","unstructured":"Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A, Svensson LG, Jehi L, Young JB, Chung MK (2020) Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1855","journal-title":"JAMA Cardiol"},{"key":"1318_CR35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, Kunichoff D, Chen Y, Ogedegbe G, Hochman JS (2020) Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2008975","journal-title":"N Engl J Med"},{"key":"1318_CR36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G (2020) Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2006923","journal-title":"N Engl J Med"},{"key":"1318_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa624","author":"SY Jung","year":"2020","unstructured":"Jung SY, Choi JC, You SH, Kim WY (2020) Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa624","journal-title":"Clin Infect Dis"},{"key":"1318_CR38","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1515","author":"K Mackey","year":"2020","unstructured":"Mackey K, King VJ, Gurley S, Kiefer M, Liederbauer E, Vela K, Sonnen P, Kansagara D (2020) Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults. Ann Intern Med. https:\/\/doi.org\/10.7326\/M20-1515","journal-title":"Ann Intern Med"},{"key":"1318_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104927","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yu J, Pan LY, Jiang HY (2020) ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2020.104927","journal-title":"Pharmacol Res"},{"issue":"11","key":"1318_CR40","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/eci.12673","volume":"46","author":"M Mizamtsidi","year":"2016","unstructured":"Mizamtsidi M, Paschou SA, Grapsa J, Vryonidou A (2016) Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes? Eur J Clin Invest 46(11):947\u2013953. https:\/\/doi.org\/10.1111\/eci.12673","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"1318_CR41","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40618-018-0977-y","volume":"42","author":"S Giannattasio","year":"2019","unstructured":"Giannattasio S, Corinaldesi C, Colletti M, Di Luigi L, Antinozzi C, Filardi T, Scolletta S, Basili S, Lenzi A, Morano S, Crescioli C (2019) The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence. J Endocrinol Invest 42(6):715\u2013725. https:\/\/doi.org\/10.1007\/s40618-018-0977-y","journal-title":"J Endocrinol Invest"},{"key":"1318_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133299","author":"T Filardi","year":"2019","unstructured":"Filardi T, Ghinassi B, Di Baldassarre A, Tanzilli G, Morano S, Lenzi A, Basili S, Crescioli C (2019) Cardiomyopathy associated with diabetes: the central role of the cardiomyocyte. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20133299","journal-title":"Int J Mol Sci"},{"issue":"10223","key":"1318_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"1318_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1017","author":"T Guo","year":"2020","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z (2020) Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017","journal-title":"JAMA Cardiol"},{"key":"1318_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3319","author":"W Guo","year":"2020","unstructured":"Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, Qin R, Wang H, Shen Y, Du K, Zhao L, Fan H, Luo S, Hu D (2020) Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. https:\/\/doi.org\/10.1002\/dmrr.3319","journal-title":"Diabetes Metab Res Rev"},{"key":"1318_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yjmcc.2016.05.012","volume":"97","author":"X Wang","year":"2016","unstructured":"Wang X, Ye Y, Gong H, Wu J, Yuan J, Wang S, Yin P, Ding Z, Kang L, Jiang Q, Zhang W, Li Y, Ge J, Zou Y (2016) The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1\u20137)-Mas axes in pressure overload-induced cardiac remodeling in male mice. J Mol Cell Cardiol 97:180\u2013190. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.05.012","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1318_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.phrs.2012.05.001","volume":"66","author":"MH Yousif","year":"2012","unstructured":"Yousif MH, Dhaunsi GS, Makki BM, Qabazard BA, Akhtar S, Benter IF (2012) Characterization of Angiotensin-(1\u20137) effects on the cardiovascular system in an experimental model of type-1 diabetes. Pharmacol Res 66(3):269\u2013275. https:\/\/doi.org\/10.1016\/j.phrs.2012.05.001","journal-title":"Pharmacol Res"},{"issue":"3","key":"1318_CR48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bcp.2014.11.013","volume":"93","author":"K Tikoo","year":"2015","unstructured":"Tikoo K, Patel G, Kumar S, Karpe PA, Sanghavi M, Malek V, Srinivasan K (2015) Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications. Biochem Pharmacol 93(3):343\u2013351. https:\/\/doi.org\/10.1016\/j.bcp.2014.11.013","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"1318_CR49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00380-016-0936-5","volume":"32","author":"YH Shin","year":"2017","unstructured":"Shin YH, Min JJ, Lee JH, Kim EH, Kim GE, Kim MH, Lee JJ, Ahn HJ (2017) The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts. Heart Vessels 32(5):618\u2013627. https:\/\/doi.org\/10.1007\/s00380-016-0936-5","journal-title":"Heart Vessels"},{"key":"1318_CR50","doi-asserted-by":"publisher","first-page":"1371758","DOI":"10.1155\/2019\/1371758","volume":"2019","author":"M Sanchez-Aguilar","year":"2019","unstructured":"Sanchez-Aguilar M, Ibarra-Lara L, Del Valle-Mondragon L, Rubio-Ruiz ME, Aguilar-Navarro AG, Zamorano-Carrillo A, Ramirez-Ortega MDC, Pastelin-Hernandez G, Sanchez-Mendoza A (2019) Rosiglitazone, a ligand to PPARgamma, improves blood pressure and vascular function through renin-angiotensin system regulation. PPAR Res 2019:1371758. https:\/\/doi.org\/10.1155\/2019\/1371758","journal-title":"PPAR Res"},{"key":"1318_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/603409","author":"W Zhang","year":"2014","unstructured":"Zhang W, Xu YZ, Liu B, Wu R, Yang YY, Xiao XQ, Zhang X (2014) Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis. ScientificWorldJournal. https:\/\/doi.org\/10.1155\/2014\/603409","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"1318_CR52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S2213-8587(15)00482-9","volume":"4","author":"MA Nauck","year":"2016","unstructured":"Nauck MA, Meier JJ (2016) The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions. Lancet Diabetes Endocrinol 4(6):525\u2013536. https:\/\/doi.org\/10.1016\/S2213-8587(15)00482-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1318_CR53","doi-asserted-by":"publisher","first-page":"117955142091297","DOI":"10.1177\/1179551420912972","volume":"13","author":"NA Trzaskalski","year":"2020","unstructured":"Trzaskalski NA, Fadzeyeva E, Mulvihill EE (2020) Dipeptidyl peptidase-4 at the interface between inflammation and metabolism. Clin Med Insights Endocrinol Diabetes 13:1179551420912972. https:\/\/doi.org\/10.1177\/1179551420912972","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"2","key":"1318_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1365-3083.2010.02488.x","volume":"73","author":"DM Yu","year":"2011","unstructured":"Yu DM, Slaitini L, Gysbers V, Riekhoff AG, Kahne T, Knott HM, De Meester I, Abbott CA, McCaughan GW, Gorrell MD (2011) Soluble CD26 \/ dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding. Scand J Immunol 73(2):102\u2013111. https:\/\/doi.org\/10.1111\/j.1365-3083.2010.02488.x","journal-title":"Scand J Immunol"},{"issue":"1","key":"1318_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/db12-0230","volume":"62","author":"J Zhong","year":"2013","unstructured":"Zhong J, Rao X, Deiuliis J, Braunstein Z, Narula V, Hazey J, Mikami D, Needleman B, Satoskar AR, Rajagopalan S (2013) A potential role for dendritic cell\/macrophage-expressing DPP4 in obesity-induced visceral inflammation. Diabetes 62(1):149\u2013157. https:\/\/doi.org\/10.2337\/db12-0230","journal-title":"Diabetes"},{"issue":"7440","key":"1318_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495(7440):251\u2013254. https:\/\/doi.org\/10.1038\/nature12005","journal-title":"Nature"},{"issue":"2","key":"1318_CR57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14728222.2017.1271415","volume":"21","author":"L Du","year":"2017","unstructured":"Du L, Yang Y, Zhou Y, Lu L, Li F, Jiang S (2017) MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets 21(2):131\u2013143. https:\/\/doi.org\/10.1080\/14728222.2017.1271415","journal-title":"Expert Opin Ther Targets"},{"key":"1318_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.03.044","author":"F Qi","year":"2020","unstructured":"Qi F, Qian S, Zhang S, Zhang Z (2020) Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.044","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1318_CR59","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA (2020) Emerging Wuhan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 9(1):601\u2013604. https:\/\/doi.org\/10.1080\/22221751.2020.1739565","journal-title":"Emerg Microbes Infect"},{"key":"1318_CR60","doi-asserted-by":"publisher","first-page":"108165","DOI":"10.1016\/j.diabres.2020.108165","volume":"163","author":"I Barchetta","year":"2020","unstructured":"Barchetta I, Cavallo MG, Baroni MG (2020) COVID-19 and diabetes: is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications. Diabetes Res Clin Pract 163:108165. https:\/\/doi.org\/10.1016\/j.diabres.2020.108165","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01318-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T23:16:14Z","timestamp":1622675774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01318-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01318-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study formal consent in not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}